Which of the following do you feel is MOST useful when assessing pretreatment risk of recurrence of patients with prostate cancer?

• 1. D’Amico risk stratification grouping (preoperative PSA, clinical stage, biopsy Gleason score)

• 2. Kattan nomogram (points assigned for preoperative PSA, clinical stage, biopsy Gleason score)

• 3. Partin tables

• 4. Percentage and number of positive biopsy cores (Poulos, Lotan)

• 5. Genomic biomarkers

• 6. Preoperative PSA velocity

• 7. Genomic biomarkers

• 8. Other